APO Research

APO RESEARCH · REPORT

cfDNA Testing

Selected research

Market Structure

Global cfDNA Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global cfDNA Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for cfDNA Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for cfDNA Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for cfDNA Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for cfDNA Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of cfDNA Testing include Illumina, Oncogenomics, Revvity, CareDx, Natera, BillionToOne, Inc., Yourgene Health, ARUP Laboratories and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global cfDNA Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of cfDNA Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents cfDNA Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the cfDNA Testing market size, projected growth trends, production technologies, key applications, and end-use industries.

cfDNA Testing Segment by Company

Illumina

Oncogenomics

Revvity

CareDx

Natera

BillionToOne, Inc.

Yourgene Health

ARUP Laboratories

Roche

cfDNA Testing Segment by Type

Targeted Sequencing

Whole Genome Sequencing

cfDNA Testing Segment by Application

Prenatal Testing

Oncology

Organ Transplant Monitoring

Others

cfDNA Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global cfDNA Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of cfDNA Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of cfDNA Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of cfDNA Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global cfDNA Testing industry.

Chapter 3: Detailed analysis of cfDNA Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, cfDNA Testingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global cfDNA Testing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Targeted Sequencing Table 3. Key Players of Whole Genome Sequencing Table 4. Global cfDNA Testing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Prenatal Testing Table 6. Key Players of Oncology Table 7. Key Players of Organ Transplant Monitoring Table 8. Key Players of Others Table 9. Global cfDNA Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global cfDNA Testing Market Size by Region (2021-2026) & (US$ Million) Table 11. Global cfDNA Testing Market Share by Region (2021-2026) Table 12. Global cfDNA Testing Market Size by Region (2027-2032) & (US$ Million) Table 13. Global cfDNA Testing Market Share by Region (2027-2032) Table 14. cfDNA Testing Industry Trends Table 15. cfDNA Testing Industry Drivers Table 16. cfDNA Testing Industry Opportunities and Challenges Table 17. cfDNA Testing Industry Restraints Table 18. Global cfDNA Testing Revenue by Company (US$ Million) & (2021-2026) Table 19. Global cfDNA Testing Revenue Market Share by Company (2021-2026) Table 20. Global cfDNA Testing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global cfDNA Testing Key Company Head Office and Area Served Table 22. Global cfDNA Testing Company, Product Type & Application Table 23. Global cfDNA Testing Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global cfDNA Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global cfDNA Testing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global cfDNA Testing Market Size by Type (2021-2026) & (US$ Million) Table 28. Global cfDNA Testing Market Size by Type (2027-2032) & (US$ Million) Table 29. Global cfDNA Testing Revenue Market Share by Type (2021-2026) Table 30. Global cfDNA Testing Revenue Market Share by Type (2027-2032) Table 31. Global cfDNA Testing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global cfDNA Testing Market Size by Application (2021-2026) & (US$ Million) Table 33. Global cfDNA Testing Market Size by Application (2027-2032) & (US$ Million) Table 34. Global cfDNA Testing Revenue Market Share by Application (2021-2026) Table 35. Global cfDNA Testing Revenue Market Share by Application (2027-2032) Table 36. Illumina Company Information Table 37. Illumina Business Overview Table 38. Illumina cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Illumina cfDNA Testing Product Portfolio Table 40. Illumina Recent Development Table 41. Oncogenomics Company Information Table 42. Oncogenomics Business Overview Table 43. Oncogenomics cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Oncogenomics cfDNA Testing Product Portfolio Table 45. Oncogenomics Recent Development Table 46. Revvity Company Information Table 47. Revvity Business Overview Table 48. Revvity cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Revvity cfDNA Testing Product Portfolio Table 50. Revvity Recent Development Table 51. CareDx Company Information Table 52. CareDx Business Overview Table 53. CareDx cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. CareDx cfDNA Testing Product Portfolio Table 55. CareDx Recent Development Table 56. Natera Company Information Table 57. Natera Business Overview Table 58. Natera cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Natera cfDNA Testing Product Portfolio Table 60. Natera Recent Development Table 61. BillionToOne, Inc. Company Information Table 62. BillionToOne, Inc. Business Overview Table 63. BillionToOne, Inc. cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. BillionToOne, Inc. cfDNA Testing Product Portfolio Table 65. BillionToOne, Inc. Recent Development Table 66. Yourgene Health Company Information Table 67. Yourgene Health Business Overview Table 68. Yourgene Health cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Yourgene Health cfDNA Testing Product Portfolio Table 70. Yourgene Health Recent Development Table 71. ARUP Laboratories Company Information Table 72. ARUP Laboratories Business Overview Table 73. ARUP Laboratories cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. ARUP Laboratories cfDNA Testing Product Portfolio Table 75. ARUP Laboratories Recent Development Table 76. Roche Company Information Table 77. Roche Business Overview Table 78. Roche cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Roche cfDNA Testing Product Portfolio Table 80. Roche Recent Development Table 81. North America cfDNA Testing Market Size by Type (2021-2026) & (US$ Million) Table 82. North America cfDNA Testing Market Size by Type (2027-2032) & (US$ Million) Table 83. North America cfDNA Testing Market Size by Application (2021-2026) & (US$ Million) Table 84. North America cfDNA Testing Market Size by Application (2027-2032) & (US$ Million) Table 85. North America cfDNA Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America cfDNA Testing Market Size by Country (2021-2026) Table 87. North America cfDNA Testing Market Size by Country (2027-2032) Table 88. Europe cfDNA Testing Market Size by Type (2021-2026) & (US$ Million) Table 89. Europe cfDNA Testing Market Size by Type (2027-2032) & (US$ Million) Table 90. Europe cfDNA Testing Market Size by Application (2021-2026) & (US$ Million) Table 91. Europe cfDNA Testing Market Size by Application (2027-2032) & (US$ Million) Table 92. Europe cfDNA Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Europe cfDNA Testing Market Size by Country (2021-2026) Table 94. Europe cfDNA Testing Market Size by Country (2027-2032) Table 95. China cfDNA Testing Market Size by Type (2021-2026) & (US$ Million) Table 96. China cfDNA Testing Market Size by Type (2027-2032) & (US$ Million) Table 97. China cfDNA Testing Market Size by Application (2021-2026) & (US$ Million) Table 98. China cfDNA Testing Market Size by Application (2027-2032) & (US$ Million) Table 99. Asia cfDNA Testing Market Size by Type (2021-2026) & (US$ Million) Table 100. Asia cfDNA Testing Market Size by Type (2027-2032) & (US$ Million) Table 101. Asia cfDNA Testing Market Size by Application (2021-2026) & (US$ Million) Table 102. Asia cfDNA Testing Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia cfDNA Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Asia cfDNA Testing Market Size by Country (2021-2026) Table 105. Asia cfDNA Testing Market Size by Country (2027-2032) Table 106. South America, Middle East & Africa cfDNA Testing Market Size by Type (2021-2026) & (US$ Million) Table 107. South America, Middle East & Africa cfDNA Testing Market Size by Type (2027-2032) & (US$ Million) Table 108. South America, Middle East & Africa cfDNA Testing Market Size by Application (2021-2026) & (US$ Million) Table 109. South America, Middle East & Africa cfDNA Testing Market Size by Application (2027-2032) & (US$ Million) Table 110. South America, Middle East & Africa cfDNA Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. South America, Middle East & Africa cfDNA Testing Market Size by Country (2021-2026) Table 112. South America, Middle East & Africa cfDNA Testing Market Size by Country (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. cfDNA Testing Product Image Figure 2. Global cfDNA Testing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global cfDNA Testing Market Share by Type: 2025 VS 2032 Figure 4. Targeted Sequencing Image Figure 5. Whole Genome Sequencing Image Figure 6. Global cfDNA Testing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global cfDNA Testing Market Share by Application: 2025 VS 2032 Figure 8. Prenatal Testing Image Figure 9. Oncology Image Figure 10. Organ Transplant Monitoring Image Figure 11. Others Image Figure 12. Global cfDNA Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 14. Global cfDNA Testing Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global cfDNA Testing Market Share by Players in 2025 Figure 17. Global Top 5 and 10 cfDNA Testing Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global cfDNA Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global cfDNA Testing Revenue Market Share by Type (2021-2032) Figure 21. Global cfDNA Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global cfDNA Testing Revenue Market Share by Application (2021-2032) Figure 23. North America cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 24. North America cfDNA Testing Market Share by Type (2021-2032) Figure 25. North America cfDNA Testing Market Share by Application (2021-2032) Figure 26. North America cfDNA Testing Market Share by Country (2021-2032) Figure 27. United States cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 28. Canada cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 29. Mexico cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 30. Europe cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 31. Europe cfDNA Testing Market Share by Type (2021-2032) Figure 32. Europe cfDNA Testing Market Share by Application (2021-2032) Figure 33. Europe cfDNA Testing Market Share by Country (2021-2032) Figure 34. Germany cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 35. France cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 36. U.K. cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 37. Italy cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 38. Russia cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 40. China cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 41. China cfDNA Testing Market Share by Type (2021-2032) Figure 42. China cfDNA Testing Market Share by Application (2021-2032) Figure 43. Asia cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 44. Asia cfDNA Testing Market Share by Type (2021-2032) Figure 45. Asia cfDNA Testing Market Share by Application (2021-2032) Figure 46. Asia cfDNA Testing Market Share by Country (2021-2032) Figure 47. Japan cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 48. South Korea cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 51. India cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 52. Australia cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa cfDNA Testing Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa cfDNA Testing Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa cfDNA Testing Market Share by Country (2021-2032) Figure 57. Brazil cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 58. South Africa cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 60. Turkey cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 61. Argentina cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 62. UAE cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 63. Egypt cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 64. Chile cfDNA Testing Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Sequencing
  • Whole Genome Sequencing
Applications
  • Prenatal Testing
  • Oncology
  • Organ Transplant Monitoring
  • Others
Companies covered
  • Illumina
  • Oncogenomics
  • Revvity
  • CareDx
  • Natera
  • BillionToOne, Inc.
  • Yourgene Health
  • ARUP Laboratories
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global cfDNA Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Targeted Sequencing
  5. 1.2.3 Whole Genome Sequencing
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global cfDNA Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Prenatal Testing
  9. 1.3.3 Oncology
  10. 1.3.4 Organ Transplant Monitoring
  11. 1.3.5 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global cfDNA Testing Growth Trends by Region
  14. 1.5.1 Global cfDNA Testing Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 cfDNA Testing Market Size by Region (2021-2026)
  16. 1.5.3 cfDNA Testing Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global cfDNA Testing Market Dynamics
  1. 2.1 cfDNA Testing Industry Trends
  2. 2.2 cfDNA Testing Industry Drivers
  3. 2.3 cfDNA Testing Industry Opportunities and Challenges
  4. 2.4 cfDNA Testing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global cfDNA Testing Revenue by Company (2021-2026)
  2. 3.2 Global cfDNA Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global cfDNA Testing Key Company Head office and Area Served
  4. 3.4 Global cfDNA Testing Company, Product Type & Application
  5. 3.5 Global cfDNA Testing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global cfDNA Testing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 cfDNA Testing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 cfDNA Testing Tier 1, Tier 2, and Tier 3
4 cfDNA Testing Market by Type
  1. 4.1 Global cfDNA Testing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global cfDNA Testing Market Size by Type (2021-2032)
  3. 4.3 Global cfDNA Testing Market Size Share by Type (2021-2032)
5 cfDNA Testing Market by Application
  1. 5.1 Global cfDNA Testing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global cfDNA Testing Market Size by Application (2021-2032)
  3. 5.3 Global cfDNA Testing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Illumina
  2. 6.1.1 Illumina Company Information
  3. 6.1.2 Illumina Business Overview
  4. 6.1.3 Illumina cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Illumina cfDNA Testing Product Portfolio
  6. 6.1.5 Illumina Recent Developments
  7. 6.2 Oncogenomics
  8. 6.2.1 Oncogenomics Company Information
  9. 6.2.2 Oncogenomics Business Overview
  10. 6.2.3 Oncogenomics cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Oncogenomics cfDNA Testing Product Portfolio
  12. 6.2.5 Oncogenomics Recent Developments
  13. 6.3 Revvity
  14. 6.3.1 Revvity Company Information
  15. 6.3.2 Revvity Business Overview
  16. 6.3.3 Revvity cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Revvity cfDNA Testing Product Portfolio
  18. 6.3.5 Revvity Recent Developments
  19. 6.4 CareDx
  20. 6.4.1 CareDx Company Information
  21. 6.4.2 CareDx Business Overview
  22. 6.4.3 CareDx cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 CareDx cfDNA Testing Product Portfolio
  24. 6.4.5 CareDx Recent Developments
  25. 6.5 Natera
  26. 6.5.1 Natera Company Information
  27. 6.5.2 Natera Business Overview
  28. 6.5.3 Natera cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Natera cfDNA Testing Product Portfolio
  30. 6.5.5 Natera Recent Developments
  31. 6.6 BillionToOne, Inc.
  32. 6.6.1 BillionToOne, Inc. Company Information
  33. 6.6.2 BillionToOne, Inc. Business Overview
  34. 6.6.3 BillionToOne, Inc. cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 BillionToOne, Inc. cfDNA Testing Product Portfolio
  36. 6.6.5 BillionToOne, Inc. Recent Developments
  37. 6.7 Yourgene Health
  38. 6.7.1 Yourgene Health Company Information
  39. 6.7.2 Yourgene Health Business Overview
  40. 6.7.3 Yourgene Health cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Yourgene Health cfDNA Testing Product Portfolio
  42. 6.7.5 Yourgene Health Recent Developments
  43. 6.8 ARUP Laboratories
  44. 6.8.1 ARUP Laboratories Company Information
  45. 6.8.2 ARUP Laboratories Business Overview
  46. 6.8.3 ARUP Laboratories cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 ARUP Laboratories cfDNA Testing Product Portfolio
  48. 6.8.5 ARUP Laboratories Recent Developments
  49. 6.9 Roche
  50. 6.9.1 Roche Company Information
  51. 6.9.2 Roche Business Overview
  52. 6.9.3 Roche cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Roche cfDNA Testing Product Portfolio
  54. 6.9.5 Roche Recent Developments
7 North America
  1. 7.1 North America cfDNA Testing Market Size (2021-2032)
  2. 7.2 North America cfDNA Testing Market Size by Type
  3. 7.2.1 North America cfDNA Testing Market Size by Type (2021-2026)
  4. 7.2.2 North America cfDNA Testing Market Size by Type (2027-2032)
  5. 7.2.3 North America cfDNA Testing Market Share by Type (2021-2032)
  6. 7.3 North America cfDNA Testing Market Size by Application
  7. 7.3.1 North America cfDNA Testing Market Size by Application (2021-2026)
  8. 7.3.2 North America cfDNA Testing Market Size by Application (2027-2032)
  9. 7.3.3 North America cfDNA Testing Market Share by Application (2021-2032)
  10. 7.4 North America cfDNA Testing Market Size by Country
  11. 7.4.1 North America cfDNA Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America cfDNA Testing Market Size by Country (2021-2026)
  13. 7.4.3 North America cfDNA Testing Market Size by Country (2027-2032)
  14. 7.4.4 North America cfDNA Testing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe cfDNA Testing Market Size (2021-2032)
  2. 8.2 Europe cfDNA Testing Market Size by Type
  3. 8.2.1 Europe cfDNA Testing Market Size by Type (2021-2026)
  4. 8.2.2 Europe cfDNA Testing Market Size by Type (2027-2032)
  5. 8.2.3 Europe cfDNA Testing Market Share by Type (2021-2032)
  6. 8.3 Europe cfDNA Testing Market Size by Application
  7. 8.3.1 Europe cfDNA Testing Market Size by Application (2021-2026)
  8. 8.3.2 Europe cfDNA Testing Market Size by Application (2027-2032)
  9. 8.3.3 Europe cfDNA Testing Market Share by Application (2021-2032)
  10. 8.4 Europe cfDNA Testing Market Size by Country
  11. 8.4.1 Europe cfDNA Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe cfDNA Testing Market Size by Country (2021-2026)
  13. 8.4.3 Europe cfDNA Testing Market Size by Country (2027-2032)
  14. 8.4.4 Europe cfDNA Testing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China cfDNA Testing Market Size (2021-2032)
  2. 9.2 China cfDNA Testing Market Size by Type
  3. 9.2.1 China cfDNA Testing Market Size by Type (2021-2026)
  4. 9.2.2 China cfDNA Testing Market Size by Type (2027-2032)
  5. 9.2.3 China cfDNA Testing Market Share by Type (2021-2032)
  6. 9.3 China cfDNA Testing Market Size by Application
  7. 9.3.1 China cfDNA Testing Market Size by Application (2021-2026)
  8. 9.3.2 China cfDNA Testing Market Size by Application (2027-2032)
  9. 9.3.3 China cfDNA Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia cfDNA Testing Market Size (2021-2032)
  2. 10.2 Asia cfDNA Testing Market Size by Type
  3. 10.2.1 Asia cfDNA Testing Market Size by Type (2021-2026)
  4. 10.2.2 Asia cfDNA Testing Market Size by Type (2027-2032)
  5. 10.2.3 Asia cfDNA Testing Market Share by Type (2021-2032)
  6. 10.3 Asia cfDNA Testing Market Size by Application
  7. 10.3.1 Asia cfDNA Testing Market Size by Application (2021-2026)
  8. 10.3.2 Asia cfDNA Testing Market Size by Application (2027-2032)
  9. 10.3.3 Asia cfDNA Testing Market Share by Application (2021-2032)
  10. 10.4 Asia cfDNA Testing Market Size by Country
  11. 10.4.1 Asia cfDNA Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia cfDNA Testing Market Size by Country (2021-2026)
  13. 10.4.3 Asia cfDNA Testing Market Size by Country (2027-2032)
  14. 10.4.4 Asia cfDNA Testing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa cfDNA Testing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa cfDNA Testing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa cfDNA Testing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa cfDNA Testing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa cfDNA Testing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa cfDNA Testing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa cfDNA Testing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa cfDNA Testing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa cfDNA Testing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa cfDNA Testing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa cfDNA Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa cfDNA Testing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa cfDNA Testing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa cfDNA Testing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research